Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, focuses on the discovery and development of targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that is in Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin. The company is also developing AR-320 is a fully human IgG1 monoclonal antibody targeting S. aureus alpha toxin to treat infections caused by methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus; AR-105, a fully human IgG1 mAb, which is in Phase II trials to target gram-negative bacteria P. aeruginosa; AR-101, a human IgM mAb, which is in Phase IIa clinical trials for the treatment of hospital-acquired pneumonia (HAP)and ventilator-associated pneumonia (VAP) caused by P. aeruginosa serotype O11; AR-401 that is in preclinical stage to treat infections caused by Acinetobacter baumannii; AR-201, a fully human IgG1 mAb preclinical program for respiratory syncytial virus; and AR-501, an anti-infective therapy, which is in Phase I/IIa clinical trial to manage chronic lung infections in cystic fibrosis patients. In addition, it is developing AR-712 and AR-701, a cocktail of two fully human immunoglobulin 1, or IgG1, mAbs, which is in Phase I/II clinical for the treatment of mild to moderate non-hospitalized COVID-19 patients. Aridis Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Los Gatos, California.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Aigh Capital Management Llc	423.36K	2021-05-13	347.02K	76.34K	Shares	2.50M
Aigh Capital Management Llc	423.36K	2021-05-13	347.02K	76.34K	Shares	2.50M
Roumell Asset Management, Llc	222.22K	2021-05-14	0	222.22K	Shares	1.31M
Roumell Asset Management, Llc	222.22K	2021-05-14	0	222.22K	Shares	1.31M
Vanguard Group Inc	149.66K	2021-05-14	147.42K	2.23K	Shares	883K
Vanguard Group Inc	149.66K	2021-05-14	147.42K	2.23K	Shares	883K
Worth Venture Partners, Llc	105.41K	2021-05-17	87.93K	17.48K	Shares	622K
Worth Venture Partners, Llc	105.41K	2021-05-17	87.93K	17.48K	Shares	622K
Minot Wealth Management Llc	72.23K	2021-04-29	132.28K	-60.05K	Shares	426K
Minot Wealth Management Llc	72.23K	2021-04-29	132.28K	-60.05K	Shares	426K
Blackrock Inc.	26.38K	2021-05-07	23.68K	2.70K	Shares	156K
Blackrock Inc.	26.38K	2021-05-07	23.68K	2.70K	Shares	156K
Wealth Architects, Llc	14.08K	2023-08-02	14.08K	0	Shares	3.10K
Wealth Architects, Llc	14.08K	2023-08-02	14.08K	0	Shares	3.10K
Perritt Capital Management Inc	10.10K	2021-05-17	0	10.10K	Shares	60K
Perritt Capital Management Inc	10.10K	2021-05-17	0	10.10K	Shares	60K
Wells Fargo & Company/Mn	1.27K	2021-05-13	341	925	Shares	7K
Wells Fargo & Company/Mn	1.27K	2021-05-13	341	925	Shares	7K
Citigroup Inc	750	2021-05-13	750	0	Shares	4K
Citigroup Inc	750	2021-05-13	750	0	Shares	4K
Morgan Stanley	500	2021-05-17	0	500	Shares	3K
Morgan Stanley	500	2021-05-17	0	500	Shares	3K
Bank Of America Corp /De/	28	2021-05-14	0	28	Shares	0
Bank Of America Corp /De/	28	2021-05-14	0	28	Shares	0
Tower Research Capital Llc ...	0	2021-05-17	653	-653	Shares	0
Tower Research Capital Llc ...	0	2021-05-17	653	-653	Shares	0
Ubs Group Ag	0	2021-05-12	454	-454	Shares	0
Ubs Group Ag	0	2021-05-12	454	-454	Shares	0
Jpmorgan Chase & Co	0	2021-02-19	4	-4	Shares	0
Victory Capital Management Inc	0	2020-08-07	1.03K	-1.03K	Shares	0
Victory Capital Management Inc	0	2020-08-07	1.03K	-1.03K	Shares	0
Jpmorgan Chase & Co	0	2021-02-19	4	-4	Shares	0
Federated Hermes, Inc.	0	2021-05-13	472	-472	Shares	0
Federated Hermes, Inc.	0	2021-05-13	472	-472	Shares	0
Concourse Financial Group S...	0	2021-05-13	0	0	Shares	0
Concourse Financial Group S...	0	2021-05-13	0	0	Shares	0
Millennium Management Llc	0	2021-02-16	11.33K	-11.33K	Shares	0
Millennium Management Llc	0	2021-02-16	11.33K	-11.33K	Shares	0

NASDAQ:ARDS

Aridis Pharmaceuticals, Inc.

Last Close

0.06

03/05 18:57

Market Cap

3.37M

Beta: 0.99

Volume Today

28.92K

Avg: 997.59K

PE Ratio

−4.42

PFCF: −0.20

Institutional trades

Institutional Ownership

Current holdings institutionals